SECTORAL ASSET MANAGEMENT INC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001274413

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q3 2026 · 76 positions · Total reported value $134.32M · Top-10 concentration 38.3% · Updated 2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

Turnover: 47.8% · 8 new · 21 cut · 14 exited

Active Share (vs S&P 500): 92.5% · vs QQQ: 96.7% — share of the book that differs from index weights (higher = more active) · ranking

In its Q3 2026 13F filing, SECTORAL ASSET MANAGEMENT INC disclosed 76 equity positions with a combined reported value of $134.32M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 38.3% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were CTNM ($9.25M), SI ($8.13M), LLY ($7.71M). By sector, the heaviest allocations are Health Care 95.8%, Industrials 3.1%. Versus the prior quarter, allocation shifted toward Industrials (+0.6pp).

Versus the prior quarter, SECTORAL ASSET MANAGEMENT INC opened 8 new positions, trimmed 21 and fully exited 14, a turnover rate of 47.8% of positions. The portfolio's overlap with the prior quarter was 76% of names.

The largest new positions opened in Q3 2026 were TNGX ($2.64M), QURE ($1.51M), ELV ($779.97K).

Of the 14 positions fully exited versus the prior quarter, the largest were DFTX ($3.68M), TRVI ($1.22M), COGT ($1.03M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • TNGX TANGO THERAPEUTICS INC · $2.64M
  • QURE UNIQURE NV · $1.51M
  • ELV ELEVANCE HEALTH INC FORMERLY · $779.97K
  • GMAB GENMAB A/S · $353.18K
  • NAMS NEWAMSTERDAM PHARMA COMPANY · $231.04K
  • NBIX NEUROCRINE BIOSCIENCES INC · $163.12K
  • ALXO ALX ONCOLOGY HLDGS INC · $125.10K
  • EYPT EYEPOINT INC · $77.50K

Fully Exited (vs previous quarter)

  • DFTX DEFINIUM THERAPEUTICS INC · prev qtr: $3.68M
  • TRVI TREVI THERAPEUTICS INC · prev qtr: $1.22M
  • COGT COGENT BIOSCIENCES INC · prev qtr: $1.03M
  • TARS TARSUS PHARMACEUTICALS INC · prev qtr: $836.16K
  • HNGE HINGE HEALTH INC · prev qtr: $725.75K
  • PRVA PRIVIA HEALTH GROUP INC · prev qtr: $621.02K
  • AGMB AGOMAB THERAPEUTICS NV · prev qtr: $564.63K
  • ONC BEONE MEDICINES LTD · prev qtr: $532.89K

Insider Transactions (Form 4)

Latest SECTORAL ASSET MANAGEMENT INC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Sectoral Asset Management is an SEC-registered 13F filer based in Montreal, Quebec, Canada. As of Q2 2026 it reported 82 US equity positions with a combined value of $143.30M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: MONTREAL, QUEBEC, Canada
  • SEC registration: 801-60079 (status: Approved), registered 2001-03-07
  • Regulatory AUM (Form ADV): $331.38M as of 2026-05-06
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds

Portfolio Structure

  • 82 positions · $143.30M reported value (Q2 2026)
  • Top 10 holdings = 39.6% of reported value
  • Largest position: CTNM (CONTINEUM THERAPEUTICS INC CL A) at 8.3%
  • Average position size: $1.75M

Sector Tilt

  • Health Care 95.9%
  • Industrials 2.5%
  • Consumer Staples 0.9%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 14 new, 17 added, 18 reduced, 9 exited
  • 33 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund is overweight Health Care (100% of top-10 holdings) with a bullish tilt toward large-cap pharma (LLY, JNJ) and biotech (VRTX, GILD), while trimming speculative positions (CTNM, DXCM, SMMT). 2. Key moves: - Added: JNJ (+24.9% shares), VRTX (+38.7%), GILD (+19.6%), LLY (+4.9%), ABBV (+0.8%). - Reduced: CTNM (-5.2%), DXCM (-26.6%), SMMT (-19.5%), AMGN (-14.7%). 3. Portfolio structure: Active, concentrated (76 positions), high conviction in Health Care, favoring established players over small-caps. 4. Per-holding one-liner: - CTNM: CONTINEUM THERAPEUTICS (biotech, unverified). - SI: SHOULDER INNOVATIONS (medtech, unverified). - LLY: ELI LILLY (big pharma). - JNJ: JOHNSON & JOHNSON (big pharma). - VRTX: VERTEX PHARMACEUTICALS (biotech). - GILD: GILEAD SCIENCES (biopharma). - AMGN: AMGEN (biotech). - ABBV: ABBVIE (big pharma). - DXCM: DEXCOM (diabetes tech). - SMMT: SUMMIT THERAPEUTICS (biotech, unverified). 5. Style summary: Health Care-focused active manager rotating into large-cap defensives (JNJ, LLY) and high-growth biotech (VRTX, GILD) while cutting underperforming small-caps.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-15 04:55

Sector Allocation

Health Care 95.8%
Technology 0.2%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 689.59K $9.25M 6.89%
6.89%
Reduce
2 430.42K $8.13M 6.06%
6.06%
Hold
3 6.66K $7.71M 5.74%
5.74%
Add
4 22.76K $6.02M 4.49%
4.49%
Add
5 7.53K $3.94M 2.93%
2.93%
Add
6 24.66K $3.67M 2.74%
2.74%
Add
7 7.86K $3.31M 2.47%
2.47%
Reduce
8 12.30K $3.22M 2.40%
2.40%
Add
9 37.23K $3.21M 2.39%
2.39%
Reduce
10 177.18K $3.00M 2.23%
2.23%
Reduce
11 115.93K $2.99M 2.23%
2.23%
Add
12 20.46K $2.99M 2.22%
2.22%
Reduce
13 30.18K $2.97M 2.21%
2.21%
Reduce
14 35.35K $2.94M 2.19%
2.19%
Reduce
15 177.29K $2.72M 2.02%
2.02%
Add
16 23.71K $2.71M 2.01%
2.01%
Add
17 87.34K $2.64M 1.97%
1.97%
Add
18 105.76K $2.64M 1.96%
1.96%
New
19 2.68K $2.57M 1.91%
1.91%
Reduce
20 22.57K $2.57M 1.91%
1.91%
Reduce
21 246.15K $2.54M 1.89%
1.89%
Add
22 167.60K $2.45M 1.82%
1.82%
Add
23 5.87K $2.39M 1.78%
1.78%
Hold
24 6.21K $2.28M 1.70%
1.70%
Reduce
25 2.87K $2.18M 1.62%
1.62%
Add
26 7.83K $2.16M 1.61%
1.61%
Add
27 9.60K $2.13M 1.58%
1.58%
Hold
28 58.10K $2.12M 1.58%
1.58%
Reduce
29 225.99K $1.98M 1.48%
1.48%
Hold
30 2.91K $1.96M 1.46%
1.46%
Reduce
31 7.01K $1.89M 1.40%
1.40%
Reduce
32 7.38K $1.82M 1.36%
1.36%
Add
33 18.08K $1.79M 1.33%
1.33%
Hold
34 72.59K $1.69M 1.26%
1.26%
Add
35 57.50K $1.64M 1.22%
1.22%
Add
36 62.42K $1.51M 1.12%
1.12%
New
37 2.69K $1.46M 1.09%
1.09%
Add
38 14.56K $1.44M 1.07%
1.07%
Add
39 15.95K $1.33M 0.99%
0.99%
Reduce
40 26.17K $1.31M 0.97%
0.97%
Reduce
41 13.04K $1.12M 0.83%
0.83%
Hold
42 5.30K $1.02M 0.76%
0.76%
Add
43 15.29K $1.01M 0.75%
0.75%
Reduce
44 11.10K $965.81K 0.72%
0.72%
Hold
45 28.57K $922.62K 0.69%
0.69%
Add
46 2.01K $779.97K 0.58%
0.58%
New
47 12.06K $752.61K 0.56%
0.56%
Reduce
48 12.04K $747.92K 0.56%
0.56%
Hold
49 14.73K $642.97K 0.48%
0.48%
Reduce
50 10.11K $612.17K 0.46%
0.46%
Hold

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 50% R 50% F1 50% (modelled on 2026-Q2; 5/10 hit)

Low-confidence forecast This fund replaces about 39% of its Top-10 each quarter and backtests at F1 66% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (11 quarters)

Avg precision 66% · recall 66% · F1 66% · avg rank error 2.5 · Top-10 turnover 39%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 60% 60% 60% LLY · UNH · MRK · JNJ · AMGN · ABT · ABBV · PFE · BSX · TMO LENZ · LLY · BOLD · UNH · MRK · ABT · JNJ · MLYS · REGN · ABBV
2024-Q2 80% 80% 80% LENZ · LLY · MRK · BOLD · UNH · ABT · JNJ · REGN · MLYS · ABBV LLY · LENZ · CTNM · UNH · MRK · JNJ · ABBV · ABT · REGN · TMO
2024-Q3 70% 70% 70% LLY · LENZ · UNH · CTNM · MRK · JNJ · ABBV · REGN · ABT · TMO LENZ · CTNM · LLY · UNH · GILD · JNJ · MLYS · REGN · PFE · TMO
2024-Q4 70% 70% 70% LENZ · CTNM · LLY · UNH · GILD · JNJ · MLYS · REGN · PFE · TMO LENZ · CTNM · LLY · UNH · GILD · MLYS · ABBV · JNJ · AMGN · BSX
2025-Q1 90% 90% 90% LENZ · CTNM · LLY · UNH · GILD · MLYS · AMGN · ABBV · JNJ · BSX LENZ · LLY · UNH · MLYS · CTNM · JNJ · GILD · AMGN · ABBV · ISRG
2025-Q2 90% 90% 90% LENZ · LLY · UNH · MLYS · CTNM · JNJ · AMGN · GILD · ABBV · ISRG LENZ · LLY · UNH · MLYS · CTNM · AMGN · VRTX · JNJ · ISRG · ABBV
2025-Q3 40% 40% 40% LENZ · LLY · UNH · MLYS · VRTX · ISRG · CTNM · AMGN · JNJ · ORIC CTNM · LLY · GPCR · ANAB · SI · RCUS · IMTX · UNH · BCAX · ORIC
2025-Q4 40% 40% 40% CTNM · LLY · GPCR · ANAB · RCUS · IMTX · SI · UNH · BCAX · ORIC EVMN · CTNM · LLY · SI · UNH · AMGN · JNJ · ABBV · VRTX · ABT
2026-Q1 80% 80% 80% EVMN · CTNM · LLY · SI · AMGN · UNH · JNJ · ABBV · VRTX · ABT EVMN · CTNM · SI · LLY · JNJ · GILD · UNH · AMGN · VRTX · INSM
2026-Q2 50% 50% 50% EVMN · CTNM · SI · LLY · JNJ · GILD · UNH · INSM · AMGN · VRTX CTNM · SI · LLY · UNH · JNJ · ORKA · BNTX · DFTX · DXCM · RCUS
2026-Q3 ★ 50% 50% 50% CTNM · SI · LLY · UNH · JNJ · BNTX · ORKA · RCUS · DXCM · DFTX CTNM · SI · LLY · JNJ · VRTX · GILD · AMGN · ABBV · DXCM · SMMT

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-12. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-12 Trading days31 Holdings36 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-12, and will update as prices arrive.

Portfolio return+4.63%Buy & hold
QQQ synthetic benchmark-11.15%Liquidity weighted
Excess return+15.78%vs benchmark
Barra annualised vol19.3%Model estimate
Realised vol28.1%Annualised in window
Weighted beta0.53Raw exposure
Factor / specific risk72% / 28%Share of variance
Top-10 concentration55.8%Of reported value
Portfolio value (start = 100)78.385.392.499.5106.610-0110-2211-12SECTORAL ASSET MANAGEMENT INCQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)+4.63%Disclosed long book
QQQ synthetic benchmark-11.15%Liquidity-weighted constituents
Model universe, equal weight+2.04%Opportunity-cost reference
Excess return+15.78%Portfolio − benchmark
Arithmetic return sum+5.00%Difference vs compounded is the cross term
Weighted raw beta0.53Weighted holding betas
Realised volatility (annualised)28.14%Daily returns in window
Barra model volatility (annualised)19.30%Factor + specific
Factor share of variance72.1%Barra factors
Specific share of variance27.9%Stock residuals
Reported value$82.5M13F long US equity

2. Return attribution

The +5.00% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 +0.64% 12.8%
Momentum & Growth 3 -1.71% -34.2%
Volatility & Tail Risk 7 +0.15% 3.0%
Industry 12 +9.20% 183.9%
Specific 1 -3.27% -65.5%
Return attribution (style + industry, %)-9.5-4.8+0.0+4.8+9.5Industrials+0.18Consumer Staples+0.20Max Drawdown-0.34Size+0.37Leverage (Downside Vol)+0.43Historical Volatility-0.96Mid Cap-0.99Turnover+1.24Residual Volatility+1.42Beta-1.67Momentum-1.72Skewness-2.17Kurtosis+3.43Health Care+8.83
Factor Type Exposure Factor return Contribution Share of |return|
Health Care Industry +0.93 +9.47% +8.83% 176.6%
Kurtosis Style +0.56 +6.17% +3.43% 68.6%
Residual Volatility Style +0.66 +2.15% +1.42% 28.4%
Turnover Style -0.29 -4.35% +1.24% 24.9%
Leverage (Downside Vol) Style -0.14 -3.05% +0.43% 8.7%
Size Style -0.19 -1.93% +0.37% 7.4%
Consumer Staples Industry +0.01 +14.46% +0.20% 3.9%
Industrials Industry +0.05 +3.55% +0.18% 3.5%
Short-term Reversal Style +0.10 +1.12% +0.11% 2.2%
Amihud Illiquidity Style +0.30 +0.30% +0.09% 1.8%
Liquidity Style +0.47 -0.20% -0.09% -1.9%
Growth Style -0.07 +1.50% -0.11% -2.1%
Max Drawdown Style +0.34 -1.01% -0.34% -6.9%
Historical Volatility Style +0.10 -9.82% -0.96% -19.1%
Mid Cap Style +0.51 -1.92% -0.99% -19.7%
Beta Style -0.34 +4.92% -1.67% -33.3%
Momentum Style +0.52 -3.32% -1.72% -34.3%
Skewness Style +0.45 -4.77% -2.17% -43.3%
Specific Specific — — -3.27% -65.5%

3. Risk attribution

Annualised volatility is 19.30%; factor risk explains 72.1% of variance and specific risk 27.9%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-63.2-31.6+0.0+31.6+63.2Beta-3.29Amihud Illiquidity-0.51Short-term Reversal+0.38Consumer Staples+0.47Size+0.99Skewness+1.14Industrials+1.46Kurtosis+1.51Mid Cap+1.87Residual Volatility+2.20Liquidity+2.52Momentum+4.90Specific+27.88Health Care+58.53
Factor Type Exposure Share of variance Vol contribution Share of vol
Health Care Industry +0.93 58.5% +11.30% 11.3%
Specific Specific — 27.9% +5.38% 5.4%
Momentum Style +0.52 4.9% +0.95% 0.9%
Liquidity Style +0.47 2.5% +0.49% 0.5%
Residual Volatility Style +0.66 2.2% +0.42% 0.4%
Mid Cap Style +0.51 1.9% +0.36% 0.4%
Kurtosis Style +0.56 1.5% +0.29% 0.3%
Industrials Industry +0.05 1.5% +0.28% 0.3%
Skewness Style +0.45 1.1% +0.22% 0.2%
Size Style -0.19 1.0% +0.19% 0.2%
Consumer Staples Industry +0.01 0.5% +0.09% 0.1%
Short-term Reversal Style +0.10 0.4% +0.07% 0.1%
Historical Volatility Style +0.10 0.3% +0.05% 0.1%
Non-linear Size Style +0.25 -0.2% -0.04% -0.0%
Amihud Illiquidity Style +0.30 -0.5% -0.10% -0.1%
Beta Style -0.34 -3.3% -0.63% -0.6%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-0.9-0.10.71.62.4Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -0.19 +2.10 -2.29
Non-linear Size +0.25 +1.68 -1.43
Mid Cap +0.51 +0.13 +0.39
Beta -0.34 +1.29 -1.63
Momentum +0.52 +0.72 -0.20
Short-term Reversal +0.10 -0.64 +0.74
Residual Volatility +0.66 -0.40 +1.06
Historical Volatility +0.10 +0.86 -0.76
Liquidity +0.47 +0.11 +0.35
Amihud Illiquidity +0.30 +1.16 -0.86
Turnover -0.29 +0.21 -0.49
Growth -0.07 +0.58 -0.65
Leverage (Downside Vol) -0.14 +0.14 -0.29
Skewness +0.45 +0.24 +0.22
Kurtosis +0.56 +0.21 +0.34
Max Drawdown +0.34 -0.08 +0.42

5. Industry allocation & Brinson

Industry allocation (weight, %)-9.318.746.674.6102.6Communication ServicesUtilitiesConsumer DiscretionaryInformation TechnologyConsumer StaplesIndustrialsHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 0.4% 73.6% -3.02% -16.67% +4.59% +10.05% -10.00% +12.26%
Health Care 93.3% 1.7% +2.71% +9.50% +18.22% -0.12% -6.21% +2.37%
Communication Services 0.0% 2.6% +0.00% -12.15% +0.05% +0.32% -0.32% +0.32%
Consumer Staples 1.4% 0.8% +4.47% +15.33% +0.13% -0.09% -0.06% -0.07%
Utilities 0.0% 0.8% +0.00% +10.14% -0.16% -0.08% +0.08% -0.08%
Consumer Discretionary 0.0% 8.8% +0.00% +5.93% -1.44% -0.52% +0.52% -0.52%
Industrials 5.0% 11.1% +6.26% +7.87% -1.12% -0.18% +0.10% -0.56%
Total +20.18% +9.34% -15.85% +13.68%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
CTNM CONTINEUM THERAPEUTICS INC Health Care 11.22% -19.75% -2.22% Reduce
LLY ELI LILLY & CO Health Care 9.35% +24.22% +2.27% Add
JNJ JOHNSON & JOHNSON Health Care 7.31% +5.92% +0.43% Add
VRTX VERTEX PHARMACEUTICALS INC Health Care 4.78% +4.63% +0.22% Add
GILD GILEAD SCIENCES INC Health Care 4.46% +13.88% +0.62% Add
AMGN AMGEN INC Health Care 4.02% +11.05% +0.44% Reduce
ABBV ABBVIE INC Health Care 3.90% +12.76% +0.50% Add
DXCM DEXCOM INC Health Care 3.90% -6.88% -0.27% Reduce
MRK MERCK & CO Health Care 3.62% +1.29% +0.05% Reduce
INSM INSMED INC Health Care 3.28% +5.79% +0.19% Add
AVBP ARRIVENT BIOPHARMA INC Health Care 3.21% -55.40% -1.78% Add
TNGX TANGO THERAPEUTICS INC Health Care 3.20% +3.13% +0.10% New
ARGX Argenx S.E. Health Care 3.11% +1.95% +0.06% Reduce
ISRG INTUITIVE SURGICAL INC Health Care 2.89% +10.55% +0.30% Hold
UNH UNITEDHEALTH GROUP INC Health Care 2.76% +9.77% +0.27% Reduce
REGN REGENERON PHARMACEUTICALS Health Care 2.64% +26.53% +0.70% Add
DHR DANAHER CORP DEL Industrials 2.58% +6.21% +0.16% Hold
ROIV ROIVANT SCIENCES LTD Health Care 2.58% +14.44% +0.37% Reduce
TMO THERMO FISHER SCIENTIFIC INC Industrials 2.38% +6.32% +0.15% Reduce
IQV IQVIA HLDGS INC Health Care 2.29% +2.11% +0.05% Reduce
Contribution rank Symbol Sector Weight Return Contribution
1 LLY Health Care 9.35% +24.22% +2.27%
2 REGN Health Care 2.64% +26.53% +0.70%
3 GILD Health Care 4.46% +13.88% +0.62%
4 ABBV Health Care 3.90% +12.76% +0.50%
5 AMGN Health Care 4.02% +11.05% +0.44%
6 JNJ Health Care 7.31% +5.92% +0.43%
7 ROIV Health Care 2.58% +14.44% +0.37%
8 MRNA Health Care 1.24% +29.14% +0.36%
9 ILMN Health Care 0.71% -22.20% -0.16%
10 DXCM Health Care 3.90% -6.88% -0.27%
11 ALNY Health Care 2.21% -35.22% -0.78%
12 AVBP Health Care 3.21% -55.40% -1.78%
13 CTNM Health Care 11.22% -19.75% -2.22%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-12 (31 trading days), the reported portfolio returned +4.63%, versus -11.15% for the QQQ synthetic benchmark — an excess of +15.78%.
  2. Return attribution: the largest positive style/industry contributions came from Health Care +8.83%, Kurtosis +3.43%, Residual Volatility +1.42%; the largest drags came from Skewness -2.17%, Momentum -1.72%, Beta -1.67%. Specific (stock-level) return contributed -3.27%.
  3. Risk attribution: Barra model volatility is 19.30% annualised; factor risk explains 72% of variance and specific risk 28%. The largest factor risk sources are Health Care 58.5%, Momentum 4.9%, Liquidity 2.5%.
  4. Style tilt: size -0.19, momentum +0.52, volatility +0.10, liquidity +0.47; the weighted raw beta is 0.53. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+91.6 pp), the largest underweight is Information Technology (-73.2 pp). Allocation contributed +20.18%, selection +9.34% and interaction -15.85%.
  6. Concentration: the top-10 positions are 55.8% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did SECTORAL ASSET MANAGEMENT INC buy in 2026-Q3?

In its 2026-Q3 13F filing, SECTORAL ASSET MANAGEMENT INC reported 76 equity positions worth $134.32M in aggregate; its largest disclosed positions were CTNM ($9.25M), SI ($8.13M), LLY ($7.71M).

How large is SECTORAL ASSET MANAGEMENT INC's portfolio?

SECTORAL ASSET MANAGEMENT INC reported $134.32M of long equity holdings across 76 positions as of 2026-Q3. Top-10 holdings account for 38.3% of reported value.

What is SECTORAL ASSET MANAGEMENT INC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/sectoral-asset-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →